Tandem Diabetes Care (TNDM): Undervalued Technology Leader
Tandem Diabetes Care has fallen over 70% YTD for several reasons. Click here to read why I rate TNDM stock a strong buy on turnaround potential in 2023.
United States Paul Strasma Mark Estes Tandem Diabetes Care Inc Wells Fargo Rear View Woman Jogging Through Forest
Source: seekingalpha.com